FdaApplication
ANDA 203021
Identifiers
- fda_app_no: ANDA203021
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2012-05-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEVIRAPINE | NEVIRAPINE | 200MG | TABLET;ORAL |
1 product